Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 | 4896 | 2019 |
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis BL Neuen, T Young, HJL Heerspink, B Neal, V Perkovic, L Billot, ... The lancet Diabetes & endocrinology 7 (11), 845-854, 2019 | 754 | 2019 |
Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial CK Chow, J Redfern, GS Hillis, J Thakkar, K Santo, ML Hackett, S Jan, ... Jama 314 (12), 1255-1263, 2015 | 697 | 2015 |
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial S Thom, N Poulter, J Field, A Patel, D Prabhakaran, A Stanton, ... Jama 310 (9), 918-929, 2013 | 473 | 2013 |
Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups: results … KW Mahaffey, MJ Jardine, S Bompoint, CP Cannon, B Neal, ... Circulation 140 (9), 739-750, 2019 | 262 | 2019 |
Sodium‐glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis C Arnott, Q Li, A Kang, BL Neuen, S Bompoint, CSP Lam, A Rodgers, ... Journal of the American Heart Association 9 (3), e014908, 2020 | 208 | 2020 |
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk A Patel, A Cass, D Peiris, T Usherwood, A Brown, S Jan, B Neal, GS Hillis, ... European journal of preventive cardiology 22 (7), 920-930, 2015 | 168 | 2015 |
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial GJ Hankey, ML Hackett, OP Almeida, L Flicker, GE Mead, MS Dennis, ... The Lancet Neurology 19 (8), 651-660, 2020 | 121 | 2020 |
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial CMP Jones, RO Day, BW Koes, J Latimer, CG Maher, AJ McLachlan, ... The Lancet 402 (10398), 304-312, 2023 | 41 | 2023 |
CREDENCE Trial Investigators V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... Canagliflozin and renal outcomes in type 2 diabetes and nephropathy 2295, //doi, 0 | 39 | |
The effect of paracetamol on core body temperature in acute traumatic brain injury: a randomised, controlled clinical trial MK Saxena, C Taylor, L Billot, S Bompoint, J Gowardman, JA Roberts, ... PLoS one 10 (12), e0144740, 2015 | 35 | 2015 |
Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive … A Patel, A Cass, D Peiris, T Usherwood, A Brown, S Jan, B Neal, GS Hillis, ... Eur J Prev Cardiol 22 (7), 920-30, 2015 | 33 | 2015 |
Salt intakes, knowledge, and behavior in Samoa: monitoring salt‐consumption patterns through the World Health Organization's Surveillance of Noncommunicable Disease Risk … J Webster, SAF Su'a, M Ieremia, S Bompoint, C Johnson, G Faeamani, ... The Journal of Clinical Hypertension 18 (9), 884-891, 2016 | 28 | 2016 |
The effect of a cardiovascular polypill strategy on pill burden M Truelove, A Patel, S Bompoint, A Brown, A Cass, GS Hillis, D Peiris, ... Cardiovascular therapeutics 33 (6), 347-352, 2015 | 28 | 2015 |
UMPIRE Collaborative Group. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial S Thom, N Poulter, J Field, A Patel, D Prabhakaran, A Stanton JAMA 310 (9), 918-929, 2013 | 25 | 2013 |
Depression outcomes among patients treated with fluoxetine for stroke recovery: the AFFINITY randomized clinical trial OP Almeida, GJ Hankey, A Ford, C Etherton-Beer, L Flicker, M Hackett, ... JAMA neurology 78 (9), 1072-1079, 2021 | 13 | 2021 |
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence J Chalmers, R Joshi, AP Kengne, T Ninomiya, Y Bi, S Bompoint, L Billot, ... Journal of hypertension 26, S21-S27, 2008 | 12 | 2008 |
Repeated measures of modified Rankin scale scores to assess functional recovery from stroke: affinity study findings A Chye, ML Hackett, GJ Hankey, E Lundström, OP Almeida, J Gommans, ... Journal of the American Heart Association 11 (16), e025425, 2022 | 10 | 2022 |
ADVANCE: Lessons from the run‐in phase of a large study in type 2 diabetes ADVANCE Collaborative Group Blood Pressure 15 (6), 340-346, 2006 | 9 | 2006 |
Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial LH Donaldson, NE Hammond, S Agarwal, S Taylor, S Bompoint, ... Critical Care and Resuscitation 24 (1), 20-28, 2022 | 3 | 2022 |